Amélie Renaud

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

Y. Pommier, J. Doroshow, Shar-yin N. Huang, 2012, Cancer research.

Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

Y. Pommier, Joel Morris, J. Doroshow, 2013, Molecular Cancer Therapeutics.

Therapeutics , Targets , and Chemical Biology Trapping of PARP 1 and PARP 2 by Clinical PARP Inhibitors

Y. Pommier, J. Doroshow, Shar-yin N. Huang, 2012 .

Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).

Yves Pommier, Keli Agama, Martin Conda-Sheridan, 2013, Journal of medicinal chemistry.

Assessing foliar chlorophyll contents with the SPAD-502 chlorophyll meter: a calibration test with thirteen tree species of tropical rainforest in French Guiana

Christopher Baraloto, Céline Leroy, Bruno Hérault, 2010, Annals of Forest Science.

5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.

Y. Pommier, F. Chen, Y. Sham, 2012, Journal of medicinal chemistry.

284 Differential Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

Y. Pommier, J. Doroshow, S. Takeda, 2012 .